BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6285388)

  • 1. Prophylactic granulocyte transfusions.
    Buckner CD; Clift RA; Sanders JE; Hersman JA; Williams B
    Prog Clin Biol Res; 1982; 88():93-100. PubMed ID: 6285388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation.
    Hersman J; Meyers JD; Thomas ED; Buckner CD; Clift R
    Ann Intern Med; 1982 Feb; 96(2):149-52. PubMed ID: 6277215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis and treatment of infection of the immunocompromised host by granulocyte transfusions.
    Buckner CD; Clift RA
    Clin Haematol; 1984 Oct; 13(3):557-72. PubMed ID: 6388932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection.
    Clarke K; Szer J; Shelton M; Coghlan D; Grigg A
    Bone Marrow Transplant; 1995 Nov; 16(5):723-6. PubMed ID: 8547874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled study of therapeutic granulocyte transfusions in granulocytopenic patients with severe infections.
    Matsue K; Harada M; Nakao S; Ueda M; Kondo K; Odaka K; Mori T; Hattori K
    Jpn J Clin Oncol; 1984 Mar; 14(1):21-30. PubMed ID: 6368906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.
    Buckner CD; Clift RA; Thomas ED; Hersman J; Sanders JE; Stewart PS; Wade JC; Murphy M; Counts G; Meyers JD
    Infection; 1983; 11(5):243-50. PubMed ID: 6417027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants.
    Clift RA; Sanders JE; Thomas ED; Williams B; Buckner CD
    N Engl J Med; 1978 May; 298(19):1052-7. PubMed ID: 417248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symposium on infectious complications of neoplastic disease (Part II). Granulocyte transfusions.
    Clift RA; Buckner CD
    Am J Med; 1984 Apr; 76(4):631-6. PubMed ID: 6324588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte transfusions in children.
    Pflieger H; Wiesneth M; Arnold R; Niethammer D; Kleihauer E
    Eur J Pediatr; 1981 Feb; 135(3):261-6. PubMed ID: 7014221
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants.
    Navari RM; Buckner CD; Clift RA; Storb R; Sanders JE; Stewart P; Sullivan KM; Williams B; Counts GW; Meyers JD
    Am J Med; 1984 Apr; 76(4):564-72. PubMed ID: 6424464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of platelet and granulocyte transfusions.
    Seidl S; Kilp M
    Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia.
    Lowenthal RM; Grossman L; Goldman JM; Storring RA; Buskard NA; Park DS; Murphy BC; Spiers AS; Galton DA
    Lancet; 1975 Feb; 1(7903):353-8. PubMed ID: 46510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of a protective environment and prophylactic granulocyte transfusion in marrow transplantation.
    Buckner CD; Clift RA; Sanders JE; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):255-7. PubMed ID: 345564
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of aplastic anemia.
    Gale RP
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience.
    Nikolajeva O; Mijovic A; Hess D; Tatam E; Amrolia P; Chiesa R; Rao K; Silva J; Veys P
    Bone Marrow Transplant; 2015 Jun; 50(6):846-9. PubMed ID: 25822222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic granulocyte transfusions during human bone marrow transplantation.
    Winston DJ; Ho WG; Young LS; Gale RP
    Am J Med; 1980 Jun; 68(6):893-7. PubMed ID: 6247910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention.
    Meyers JD
    Birth Defects Orig Artic Ser; 1984; 20(1):101-17. PubMed ID: 6329356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.